The stock of Structure Therapeutics Inc ADR (GPCR) has seen a 10.27% increase in the past week, with a 4.30% gain in the past month, and a -18.04% decrease in the past quarter. The volatility ratio for the week is 4.11%, and the volatility levels for the past 30 days are at 6.14% for GPCR. The simple moving average for the past 20 days is 12.34% for GPCR’s stock, with a -17.40% simple moving average for the past 200 days.
Is It Worth Investing in Structure Therapeutics Inc ADR (NASDAQ: GPCR) Right Now?
The 36-month beta value for GPCR is also noteworthy at -2.91. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 6 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for GPCR is 54.18M, and at present, short sellers hold a 18.20% of that float. The average trading volume of GPCR on January 29, 2025 was 864.42K shares.
GPCR) stock’s latest price update
The stock price of Structure Therapeutics Inc ADR (NASDAQ: GPCR) has jumped by 7.31 compared to previous close of 28.71. Despite this, the company has seen a gain of 10.27% in its stock price over the last five trading days. benzinga.com reported 2025-01-06 that JPMorgan has reset the valuation for Viking Therapeutics Inc. VKTX and Structure Therapeutics Inc. GPCR.
Analysts’ Opinion of GPCR
Many brokerage firms have already submitted their reports for GPCR stocks, with Stifel repeating the rating for GPCR by listing it as a “Buy.” The predicted price for GPCR in the upcoming period, according to Stifel is $50 based on the research report published on January 08, 2025 of the current year 2025.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see GPCR reach a price target of $80. The rating they have provided for GPCR stocks is “Buy” according to the report published on December 04th, 2024.
Morgan Stanley gave a rating of “Overweight” to GPCR, setting the target price at $118 in the report published on September 23rd of the previous year.
GPCR Trading at 1.93% from the 50-Day Moving Average
After a stumble in the market that brought GPCR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -50.89% of loss for the given period.
Volatility was left at 6.14%, however, over the last 30 days, the volatility rate increased by 4.11%, as shares surge +6.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.76% lower at present.
During the last 5 trading sessions, GPCR rose by +10.95%, which changed the moving average for the period of 200-days by -22.98% in comparison to the 20-day moving average, which settled at $27.44. In addition, Structure Therapeutics Inc ADR saw 13.61% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for GPCR
Current profitability levels for the company are sitting at:
- -107.05 for the present operating margin
- 0.12 for the gross margin
The net margin for Structure Therapeutics Inc ADR stands at -83.25. The total capital return value is set at -0.16. Equity return is now at value -20.36, with -19.30 for asset returns.
Based on Structure Therapeutics Inc ADR (GPCR), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -23.27. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -9.14.
Currently, EBITDA for the company is -102.46 million with net debt to EBITDA at 1.19. When we switch over and look at the enterprise to sales, we see a ratio of 1208.4. The liquidity ratio also appears to be rather interesting for investors as it stands at 27.63.
Conclusion
In summary, Structure Therapeutics Inc ADR (GPCR) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
